Letter
CSM warning on atypical psychotics and stroke may be detrimental for dementia
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7450.1262-b (Published 20 May 2004) Cite this as: BMJ 2004;328:1262
- Donald Mowat, consultant in old age psychiatry (donald.mowat@gpct.grampian.scot.nhs.uk),
- Douglas Fowlie, consultant in old age psychiatry
- Royal Cornhill Hospital, Aberdeen AB25 2ZH
- Tom MacEwan, consultant in old age psychiatry
- Royal Cornhill Hospital, Aberdeen AB25 2ZH
EDITOR—On 9 March the Committee on Safety of Medicines (CSM) advised avoiding olanzapine and risperidone for patients with dementia, reflecting concern over the excess risk of stroke.1
Antipsychotic drugs have long been used (off licence) in dementia to treat neuropsychiatric disturbance and are highly effective.2 Atypical antipsychotic drugs have recently …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.